Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alkido Pharma Inc (AIKI)

0.5823   0.002 (0.38%) 10-23 23:49
Open: 0.5782 Pre. Close: 0.5801
High: 0.5885 Low: 0.57
Volume: 309,578 Market Cap: 20M
Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, the Company is constantly seeking to grow its pipeline to treat its unmet medical needs in oncology.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.59 - 0.593 0.593 - 0.596
Low: 0.563 - 0.566 0.566 - 0.569
Close: 0.575 - 0.58 0.58 - 0.584

Technical analysis

as of: 2020-10-23 4:40:23 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.72     One year: 0.81
Support: Support1: 0.50    Support2: 0.42
Resistance: Resistance1: 0.62    Resistance2: 0.69
Pivot: 0.59
Moving Average: MA(5): 0.58     MA(20): 0.59
MA(100): 0.78     MA(250): 0.93
MACD: MACD(12,26): -0.02     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 26.74     %D(3): 24.79
RSI: RSI(14): 45.00
52-week: High: 5.52  Low: 0.48  Change(%): -52.7
Average Vol(K): 3-Month: 185426  10-Days: 53791

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AIKI has closed above bottom band by 36.8%. Bollinger Bands are 70% narrower than normal. The narrow width of the bands suggests low volatility as compared to AIKI's normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 30 Sep 2020
Alkido Pharma Inc. (NASDAQ:AIKI) Announce Updates From Cogia BioTech Efforts To Use AI In Targeted PDA Treatment - BP Journal

Fri, 26 Jun 2020
AIkido Pharma Inc. Provides Update to Machine Learning Pancreatic Cancer Research - PRNewswire

Thu, 28 May 2020
AIkido Pharma Announces Publication of Results from Sponsored Research at Wake Forest University - PRNewswire

Tue, 19 May 2020
AIkido Pharma Inc. Announces Distribution of Hoth Dividend - Yahoo Finance

Tue, 12 May 2020
What You Must Know About AIkido Pharma Inc.'s (NASDAQ:AIKI) Beta Value - Yahoo Finance UK

Wed, 15 Apr 2020
AIkido Pharma Inc. Announces Closing of $14.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - PRNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 29
% Held by Insiders 5.64
% Held by Institutions 17.45
Shares Short (K) 1,760
Shares Short P. Month (K) 56

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -91966.66
Return on Assets (ttm) -23.2
Return on Equity (ttm) -61.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -4
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 2259.32
Price to Cash Flow -5.37

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1980-05-11
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.